Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma |
Asthma | Phase 2 | Spain Hungary South Africa Guatemala Colombia Poland United Kingdom Bulgaria View All |
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® |
Asthma | Korea, Republic of | |
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. |
Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic | Phase 2 | United States Greece Spain Italy View All |
Roll-over Study to Allow Continued Access to Ribociclib |
Metastatic Breast Cancer | Phase 4 | United States Turkey Brazil Poland Vietnam Hong Kong Italy South Africa Costa Rica Argentina Taiwan View All |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase 3 | India Greece United States Slovakia Spain Poland South Africa Argentina Portugal Brazil Italy Turkey France Romania Slovenia Japan Mexico Canada China Puerto Rico United Kingdom Bulgaria Croatia Sweden Estonia View All |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis |
Relapsing Multiple Sclerosis | Phase 3 | Spain United States Belgium China Switzerland Lebanon Colombia Slovakia Netherlands Argentina Poland India Ireland Guatemala Malaysia Italy Croatia Bulgaria Latvia Chile Hong Kong Denmark United Kingdom View All |
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab |
Extensive Stage Small Cell Lung Cancer | Phase 1, Phase 2 | United States Spain Germany France View All |
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer |
Non-Small Cell Lung Cancer | Phase 3 | United States Turkey Romania Spain Jordan Lebanon Greece Australia Italy India Thailand China Serbia Hungary Argentina Korea, Republic of Mexico Norway Slovenia Vietnam Hong Kong Brazil Malaysia Canada Portugal Colombia Denmark Czech Republic Bulgaria Iceland Poland Chile United Kingdom Taiwan Estonia Finland Croatia View All |
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis |
Lupus Nephritis | Phase 3 | United States Germany France India Thailand Spain Colombia China Brazil United Kingdom Romania Hungary Korea, Republic of Argentina Italy Guatemala Vietnam Taiwan Lithuania Malaysia Hong Kong Mexico Canada Czech Republic Chile Singapore Estonia View All |
Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia |
Primary Hypercholesterolemia, Mixed Dyslipidemia | China |